Enzymotec Ltd. Announces Closing of Upsized Secondary Public Offering, Including Full Exercise of the Underwriters' Option to...
06 March 2014 - 8:05AM
Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced the
closing of a registered public offering by certain selling
shareholders of 5,403,685 ordinary shares at $28.00 per share,
which includes 704,828 shares purchased pursuant to the full
exercise of the underwriters' option to purchase additional
shares. The Company did not receive any proceeds from the sale
of these shares.
BofA Merrill Lynch and Jefferies LLC acted as joint
book-running managers for the offering. Wells Fargo Securities, LLC
acted as lead manager for the offering. Canaccord Genuity Inc. and
Wedbush Securities Inc. acted as co-managers for the offering.
The offering was made solely by means of a
prospectus, copies of which may be obtained from either: BofA
Merrill Lynch, 222 Broadway, New York, NY 10038, Attention:
Prospectus Department or emailing dg.prospectus_requests@baml.com;
or Jefferies LLC, 520 Madison Ave, 12th Floor, New York, NY 10022,
877-547-6340, email: Prospectus_Department@Jefferies.com.
A registration statement relating to these
securities has been declared effective by the Securities and
Exchange Commission. This press release shall not constitute an
offer to sell or the solicitation of an offer to buy nor shall
there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any
such state or jurisdiction.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty
lipid-based products and solutions. The Company develops,
manufactures and markets innovative bio-active lipid ingredients,
as well as final products, based on sophisticated processes and
technologies.
CONTACT: ICR
Katie Turner
646-277-1228
Katie.Turner@icrinc.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More News Articles